|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Recro Pharma Inc. (REPH)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-05-17 Purchase |
2019-05-21 4:11 pm |
Recro Pharma Inc. | REPH | Ajdler Arnaud Director |
40,000 | $9 | $360,000 | 1,104,546 (Direct Indirect) |
View |
| 2019-05-13 Sale |
2019-05-15 4:06 pm |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
144,806 | $8.89 | $1,287,296 | 342,947 (Indirect Direct) |
View |
| 2018-05-24 Sale |
2018-05-24 5:02 pm |
Recro Pharma Inc. | REPH | Broadfin Healthcare Master Fund Ltd Broadfin Capital LLC KOTLER KEVIN 10% Owner |
188,000 | $5.815 | $1,093,182 | 2,206,725 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-05 Exercise |
2019-06-07 5:19 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
2,500 | $0 | 32,248 (Direct) |
View |
| 2019-06-05 Tax Withholding |
2019-06-07 5:19 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
719 | $9.55 | 32,248 (Direct) |
View |
| 2019-06-05 Exercise |
2019-06-07 5:19 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
2,500 | $0 | 32,248 (Direct) |
View |
| 2019-05-13 Exercise |
2019-05-15 4:06 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
123,500 | $2.47 | 342,947 (Direct) |
View |
| 2019-05-13 Exercise |
2019-05-15 4:06 pm |
N/A 2024-12-17 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
123,500 | $2.47 | 342,947 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-13 10:43 am |
N/A N/A |
Recro Pharma Inc. | REPH | Flynn Karen Director |
7,955 | $0 | 28,212 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-13 10:43 am |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | Flynn Karen Director |
10,888 | $8.8 | 28,212 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:28 pm |
N/A N/A |
Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director |
7,955 | $0 | 28,912 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:28 pm |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director |
10,888 | $8.8 | 28,912 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:27 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Ashton William Director |
7,955 | $0 | 27,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:27 pm |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | Ashton William Director |
10,888 | $8.8 | 27,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:27 pm |
N/A N/A |
Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director |
7,955 | $0 | 27,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:27 pm |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director |
10,888 | $8.8 | 27,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:26 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Weisman Wayne Director |
7,955 | $0 | 34,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:26 pm |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | Weisman Wayne Director |
10,888 | $8.8 | 34,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:25 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
7,955 | $0 | 22,987 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:25 pm |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
10,888 | $8.8 | 22,987 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:25 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Berelowitz Michael Director |
7,955 | $0 | 27,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:25 pm |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | Berelowitz Michael Director |
10,888 | $8.8 | 27,412 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:24 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Ajdler Arnaud Director |
7,955 | $0 | 1,064,546 (Direct) |
View |
| 2019-05-09 Option Award |
2019-05-10 4:24 pm |
N/A 2029-05-09 |
Recro Pharma Inc. | REPH | Ajdler Arnaud Director |
10,888 | $8.8 | 1,064,546 (Direct) |
View |
| 2019-03-25 Option Award |
2019-03-27 5:44 pm |
N/A 2029-03-25 |
Recro Pharma Inc. | REPH | Ajdler Arnaud Director |
20,000 | $6.41 | 20,000 (Direct) |
View |
| 2019-01-18 Option Award |
2019-02-19 4:12 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
12,857 | $0 | 60,000 (Direct) |
View |
| 2019-01-18 Option Award |
2019-02-19 4:12 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
5,750 | $0 | 60,000 (Direct) |
View |
| 2019-01-18 Tax Withholding |
2019-02-19 4:12 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
1,880 | $7.99 | 60,000 (Direct) |
View |
| 2019-01-18 Option Award |
2019-02-19 4:12 pm |
N/A 2029-01-18 |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
60,000 | $7.99 | 60,000 (Direct) |
View |
| 2019-01-18 Option Award |
2019-02-19 4:12 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
14,464 | $0 | 67,500 (Direct) |
View |
| 2019-01-18 Exercise |
2019-02-19 4:12 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
6,400 | $0 | 67,500 (Direct) |
View |
| 2019-01-18 Tax Withholding |
2019-02-19 4:12 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
1,782 | $7.99 | 67,500 (Direct) |
View |
| 2019-01-18 Option Award |
2019-02-19 4:12 pm |
N/A 2029-01-18 |
Recro Pharma Inc. | REPH | Celano Michael COO |
67,500 | $7.99 | 67,500 (Direct) |
View |
| 2019-01-18 Exercise |
2019-02-19 4:12 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
6,400 | $0 | 67,500 (Direct) |
View |
| 2019-01-18 Option Award |
2019-02-19 4:11 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
40,864 | $0 | 220,872 (Direct) |
View |
| 2019-01-18 Exercise |
2019-02-19 4:11 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
5,000 | $0 | 220,872 (Direct) |
View |
| 2019-01-18 Tax Withholding |
2019-02-19 4:11 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
1,425 | $7.99 | 220,872 (Direct) |
View |
| 2019-01-18 Option Award |
2019-02-19 4:11 pm |
N/A 2029-01-18 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
190,700 | $7.99 | 220,872 (Direct) |
View |
| 2019-01-18 Exercise |
2019-02-19 4:11 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
5,000 | $0 | 220,872 (Direct) |
View |
| 2019-01-18 Option Award |
2019-01-23 4:08 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
35,801 | $0 | 215,809 (Direct) |
View |
| 2019-01-18 Exercise |
2019-01-23 4:08 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
5,000 | $0 | 215,809 (Direct) |
View |
| 2019-01-18 Tax Withholding |
2019-01-23 4:08 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
1,425 | $7.99 | 215,809 (Direct) |
View |
| 2019-01-18 Option Award |
2019-01-23 4:08 pm |
N/A 2029-01-18 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
171,184 | $7.99 | 215,809 (Direct) |
View |
| 2019-01-18 Exercise |
2019-01-23 4:08 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
5,000 | $0 | 215,809 (Direct) |
View |
| 2019-01-18 Option Award |
2019-01-23 4:06 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
12,672 | $0 | 60,592 (Direct) |
View |
| 2019-01-18 Exercise |
2019-01-23 4:06 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
6,400 | $0 | 60,592 (Direct) |
View |
| 2019-01-18 Tax Withholding |
2019-01-23 4:06 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
1,782 | $7.99 | 60,592 (Direct) |
View |
| 2019-01-18 Option Award |
2019-01-23 4:06 pm |
N/A 2029-01-18 |
Recro Pharma Inc. | REPH | Celano Michael COO |
60,592 | $7.99 | 60,592 (Direct) |
View |
| 2019-01-18 Exercise |
2019-01-23 4:06 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
6,400 | $0 | 60,592 (Direct) |
View |
| 2019-01-18 Option Award |
2019-01-23 4:05 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
11,264 | $0 | 53,859 (Direct) |
View |
| 2019-01-18 Option Award |
2019-01-23 4:05 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
5,750 | $0 | 53,859 (Direct) |
View |
| 2019-01-18 Tax Withholding |
2019-01-23 4:05 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
1,880 | $7.99 | 53,859 (Direct) |
View |
| 2019-01-18 Option Award |
2019-01-23 4:05 pm |
N/A 2029-01-18 |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
53,859 | $7.99 | 53,859 (Direct) |
View |
| 2019-01-02 Tax Withholding |
2019-01-04 6:28 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Celano Michael COO |
1,702 | $7.41 | 26,773 (Direct) |
View |
| 2019-01-02 Tax Withholding |
2019-01-04 5:39 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
979 | $7.41 | 13,021 (Direct) |
View |
| 2019-01-02 Tax Withholding |
2019-01-04 5:37 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
4,223 | $7.41 | 175,008 (Direct) |
View |
| 2019-01-02 Tax Withholding |
2019-01-04 4:40 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO |
4,223 | $7.41 | 175,008 (Direct) |
View |
| 2019-01-02 Tax Withholding |
2019-01-04 4:37 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
979 | $7.41 | 13,021 (Direct) |
View |
| 2018-06-05 Exercise |
2018-06-07 4:33 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
2,500 | $0 | 14,000 (Direct) |
View |
| 2018-06-05 Exercise |
2018-06-07 4:33 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David CFO |
2,500 | $0 | 14,000 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:57 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Ashton William Director |
13,274 | $0 | 19,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:57 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Ashton William Director |
13,274 | $0 | 19,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:55 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Flynn Karen Director |
13,274 | $0 | 20,257 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:55 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Flynn Karen Director |
13,274 | $0 | 20,257 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:54 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Weisman Wayne Director |
13,274 | $0 | 26,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:54 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Weisman Wayne Director |
13,274 | $0 | 26,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:53 pm |
N/A N/A |
Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director |
13,274 | $0 | 19,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:53 pm |
N/A N/A |
Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director |
13,274 | $0 | 19,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:51 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Berelowitz Michael Director |
13,274 | $0 | 19,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:51 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Berelowitz Michael Director |
13,274 | $0 | 19,457 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:50 pm |
N/A N/A |
Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director |
13,274 | $0 | 20,957 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:50 pm |
N/A N/A |
Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director |
13,274 | $0 | 20,957 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:48 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
8,849 | $0 | 15,032 (Direct) |
View |
| 2018-05-12 Exercise |
2018-05-14 4:48 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
8,849 | $0 | 15,032 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-10 7:01 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
8,965 | $11.32 | 8,965 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-10 7:00 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | Ashton William Director |
8,965 | $11.32 | 8,965 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-10 6:59 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | Berelowitz Michael Director |
8,965 | $11.32 | 8,965 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-10 6:58 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director |
8,965 | $11.32 | 8,965 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-10 6:57 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director |
8,965 | $11.32 | 8,965 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-10 6:56 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | Weisman Wayne Director |
8,965 | $11.32 | 8,965 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-10 6:54 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | Flynn Karen Director |
8,965 | $11.32 | 8,965 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-08 5:29 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Ashton William Director |
6,183 | $0 | 6,183 (Direct) |
View |
| 2018-05-04 Option Award |
2018-05-08 5:29 pm |
N/A 2028-05-04 |
Recro Pharma Inc. | REPH | Ashton William Director |
5,742 | $11.32 | 6,183 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 21 Jul 2019 04:29:20 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |